This webinar highlights the recently released SRS Acquiom 2019 Life Sciences M&A Study, which gives a detailed look at deal terms and earnout achievement rates by year, sector and stage of development. The study draws from our experience as a professional shareholder representative on more than 100 structured life sciences deals involving almost 1,000 milestones potentially worth over $30 billion.

The webinar discussion points include:

  • Key issues in negotiating these agreements
  • Best practices for optimizing outcomes after the deal is announced
  • An analysis of which milestones actually get paid, and when

This webinar was produced in partnership with the NVCA and was recorded on November 12, 2019.\

Duration: 58 minutes


  • Don Morrissey – Head of Life Sciences
  • Sara Wilcox – Executive Director, Contract Administration
Related Insights